Literature DB >> 15142229

Creutzfeldt-Jakob disease presenting as progressive supranuclear palsy.

K A Josephs1, Y Tsuboi, D W Dickson.   

Abstract

Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by an akinetic rigid syndrome with vertical supranuclear ophthalmoplegia, early falls, and levodopa resistance. The pathological substrate of PSP consists of filamentous tau degenerative lesions affecting neurons and glia. Other disorders can present with a similar clinical picture, most commonly corticobasal degeneration and multiple system atrophy. Non-neurodegenerative disorders are rare causes of the PSP syndrome. In this report we describe clinical and pathological features of two cases of Creutzfeldt-Jakob disease (CJD) presenting with the PSP syndrome and discuss which features may help prevent misdiagnosis. To our knowledge, this is the first report of cases of CJD with autopsy confirmation that presented with a PSP syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15142229     DOI: 10.1111/j.1468-1331.2004.00780.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  10 in total

1.  Supranuclear Gaze Abnormality in Sporadic-Creutzfeldt Jacob Disease.

Authors:  Selen Gür Özmen; Hakan Gürvit; Haşmet A Hanağasi; Meltem Hale Alpsan Gökmen; Murat Emre
Journal:  Noro Psikiyatr Ars       Date:  2014-03-01       Impact factor: 1.339

Review 2.  Creutzfeldt-Jakob disease: a case report and differential diagnoses.

Authors:  Gotaro Kojima; Brent K Tatsuno; Michiko Inaba; Stephanie Velligas; Kamal Masaki; Kore K Liow
Journal:  Hawaii J Med Public Health       Date:  2013-04

3.  Pathologic correlates of supranuclear gaze palsy with parkinsonism.

Authors:  W R W Martin; J Hartlein; B A Racette; N Cairns; J S Perlmutter
Journal:  Parkinsonism Relat Disord       Date:  2017-02-24       Impact factor: 4.891

Review 4.  Eye Movement Disorders in Movement Disorders.

Authors:  Panagiotis Kassavetis; Diego Kaski; Tim Anderson; Mark Hallett
Journal:  Mov Disord Clin Pract       Date:  2022-02-16

Review 5.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Aissa Haman; Bruce L Miller
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

Review 6.  MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy.

Authors:  Igor N Petrovic; Antonio Martin-Bastida; Luke Massey; Helen Ling; Sean S O'Sullivan; David R Williams; Janice L Holton; Tamas Revesz; James W Ironside; Andrew J Lees; Laura Silveira-Moriyama
Journal:  J Neurol       Date:  2012-11-21       Impact factor: 4.849

7.  The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.

Authors:  Samir Abu-Rumeileh; Sabina Capellari; Michelangelo Stanzani-Maserati; Barbara Polischi; Paolo Martinelli; Paola Caroppo; Anna Ladogana; Piero Parchi
Journal:  Alzheimers Res Ther       Date:  2018-01-11       Impact factor: 6.982

Review 8.  Clinical Approach to Supranuclear Brainstem Saccadic Gaze Palsies.

Authors:  Alexandra Lloyd-Smith Sequeira; John-Ross Rizzo; Janet C Rucker
Journal:  Front Neurol       Date:  2017-08-23       Impact factor: 4.003

9.  Prevalence and Treatments of Movement Disorders in Prion Diseases: A Longitudinal Cohort Study.

Authors:  Danielle Sequeira; Akin Nihat; Tzehow Mok; Thomas Coysh; Peter Rudge; John Collinge; Simon Mead
Journal:  Mov Disord       Date:  2022-07-16       Impact factor: 9.698

10.  Brain dopamine transporter binding and glucose metabolism in progressive supranuclear palsy-like creutzfeldt-jakob disease.

Authors:  Eero Rissanen; Valtteri Kaasinen; Pirkko Sonninen; Matias Röyttä; Markku Päivärinta
Journal:  Case Rep Neurol       Date:  2014-01-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.